![Harry Lamble](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Harry Lamble active positions
Companies | Position | Start | End |
---|
Career history of Harry Lamble
Former positions of Harry Lamble
Companies | Position | Start | End |
---|---|---|---|
Sense Biodetection Ltd.
![]() Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 2013-12-31 | 2023-01-29 |
Chief Executive Officer | 2013-12-31 | 2021-07-19 | |
Founder | 2013-12-31 | 2023-01-29 | |
Corporate Officer/Principal | 2021-07-19 | 2023-01-29 | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 2009-12-16 | - |
Corporate Secretary | - | - |
Training of Harry Lamble
University of Bath | Doctorate Degree |
Cranfield University | Masters Business Admin |
Statistics
International
United Kingdom | 5 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Sense Biodetection Ltd.
![]() Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Health Services |
- Stock Market
- Insiders
- Harry Lamble
- Experience